Christelle Boglione‐Kerrien

Author

Centre Hospitalier Universitaire de Rennes ORCID

Also Known As

Boglione-Kerrien, C., C Boglione-Kerrien, C. Boglione-Kerrien, C. Boglione-kerrien, C. Boglione‐Kerrien, Christelle Boglione-Kerrien, Christelle Boglione‐Kerrien

Publications

219

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire de Rennes Inserm Université de Rennes CIC Rennes Institut de Recherche en Santé, Environnement et Travail

About

Christelle Boglione‐Kerrien is an author at Centre Hospitalier Universitaire de Rennes specializing in medicine, pharmacotherapy, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	83
2	Pharmacology	2	2	55
3	Natural Sciences	1	1	20
4	Biochemistry	1	1	20
5	Pathology	1	1	17

Christelle Boglione‐Kerrien

Publications

179

Citations

H-Index

Page 1

	Year	Citations
Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different? Florian Reizine, Kieran Pinceaux, Mathieu Léderlin, Journal of Fungi	2021	46
Population Pharmacokinetics of Posaconazole Tablets and Monte Carlo Simulations To Determine whether All Patients Should Receive the Same Dose Antoine Petitcollin, Christelle Boglione‐Kerrien, Camille Tron, Antimicrobial Agents and Chemotherapy	2017	37
Safety study and therapeutic drug monitoring of the oral tablet formulation of posaconazole in patients with haematological malignancies Christelle Boglione‐Kerrien, Stéphane Picard, Camille Tron, Journal of Cancer Research and Clinical Oncology Drug SafetyTherapeutic Drug MonitoringOral Tablet FormulationMedicineSafety Study	2017	35
Increased inhibition of cytochrome P450 3A4 with the tablet formulation of posaconazole Antoine Petitcollin, Romain Crochette, Camille Tron, Drug Metabolism and Pharmacokinetics Molecular PharmacologyMedicinal ChemistryCytochrome P450 3A4Pharmacological StudyBiochemistry	2016	20
Influenza- and COVID-19-associated pulmonary aspergillosis: are the pictures different? Florian Reizine, Kieran Pinceaux, Mathieu Léderlin, Pulmonary CareIpa PatientsRespiratory DiseasesCovid-19-associated Pulmonary AspergillosisClinical Epidemiology	2021	17
Contribution of voriconazole N‐oxide plasma concentration measurements to voriconazole therapeutic drug monitoring in patients with invasive fungal infection Christelle Boglione‐Kerrien, Jeff Morçet, Lucie‐Marie Scailteux, Mycoses	2023	13
Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis Brendan Le Daré, Christelle Boglione‐Kerrien, Florian Reizine, Critical Care Covid-19-associated Pulmonary AspergillosisAntifungal AgentsRespiratory InfectionIntegrative ManagementInfectious Respiratory Disease	2021	11

Page 1